Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Net loss of approximately $36 million, primarily driven by a $63 million expense associated with legacy litigation. Cash and cash equivalents of approximately $423 million.
Organic revenue CAGR (2024-2027) of approximately 10%, to approximately $15.5 billion to $16.0 billion of revenue. Adjusted diluted EPS CAGR (2024-2027) of more than 15%.
Posted In: GXO